{"id":"https://genegraph.clinicalgenome.org/r/0b0d57ba-28e6-46a3-a753-9b18be3846ebv1.0","type":"EvidenceStrengthAssertion","dc:description":"GET3 was evaluated for autosomal recessive dilated cardiomyopathy (DCM). GET3 is a cytosolic chaperone that mediates insertion of TA (tail-anchored) proteins into the endoplasmic reticulum (ER) membrane. Homozygous KO mice were embryonic lethal, whereas heterozygous mice did not exhibit a phenotype. Two siblings affected with childhood onset, quickly progressing dilated cardiomyopathy had compound heterozygous variants in GET3 that segregated with disease. GET3 expression in both patientsâ€™ samples was markedly reduced compared to controls. GET3 KO zebrafish showed abnormal cardiac contractions and decreased blood flow, thinner walls and less organized Z-lines with irregular intercalated discs compared to heterozygous clutchmates. None of the homozygous fish survived past 8dpf. Injection of wild-type human GET mRNA into GET3 KO zebrafish embryos significantly rescued the phenotype, whereas injection with either mutant mRNA had no significant effect. In summary, there is limited evidence to support this gene-disease relationship. More evidence is needed to support the relationship of GET3 with AR DCM. This classification was approved by the ClinGen Dilated Cardiomyopathy Working Group on 07/26/2024 (SOP Version 10)","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/0b0d57ba-28e6-46a3-a753-9b18be3846eb","GCISnapshot":"https://genegraph.clinicalgenome.org/r/605f9805-5af1-445a-911a-d31ebff15125","calculatedEvidenceStrength":"Limited","contributions":[{"agent":"https://genegraph.clinicalgenome.org/agent/10035","role":"SecondaryContributor"},{"id":"https://genegraph.clinicalgenome.org/r/605f9805-5af1-445a-911a-d31ebff15125_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10035","date":"2025-07-31T18:00:07.183Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/605f9805-5af1-445a-911a-d31ebff15125_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10035","date":"2025-05-02T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/605f9805-5af1-445a-911a-d31ebff15125_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/605f9805-5af1-445a-911a-d31ebff15125_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fb8ecf7b-90a1-443e-9391-bd74153ec848","type":"EvidenceLine","dc:description":"Model was not scored due to embryonic lethality of homozygous KO mice","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/99b7b3dd-df60-4453-98b7-de19441c2f57","type":"Finding","dc:description":"n/a - model was not scored due to embryonic lethality of homozygous KO mice","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16797549","rdfs:label":"GET3 KO mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/b7c90e08-261b-49a4-ba69-d10961af7943","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/88da4e9e-a64a-4b56-bec0-9a8eaf7a95b2","type":"Finding","dc:description":"Injection of wild-type showed significant reduction of decreased/absent blood flow and cardiac death","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31461301","rdfs:label":"Zebrafish rescue","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/605f9805-5af1-445a-911a-d31ebff15125_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7f65e288-0a98-48e8-86de-c2336a71d2d1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f7ce1bfe-8e10-49b5-a2b7-d4565c5d0bb4","type":"Finding","dc:description":"Protein expression levels in skin fibroblasts of patient II:2 compared to healthy controls was significantly decreased","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31461301","rdfs:label":"Western blot","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/605f9805-5af1-445a-911a-d31ebff15125_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d3f95b49-7620-4250-a794-c9af895f281b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e433e2f3-7a23-45d2-b1f3-b7d297e7ebc2","type":"EvidenceLine","dc:description":"Avoids nonsense mediated decay, within the last 50bp in penultimate exon. Additionally, in cis with GET3 c.867C>G (p.Cys289Trp), score modified to 1 pt","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e433e2f3-7a23-45d2-b1f3-b7d297e7ebc2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31461301","allele":{"id":"https://genegraph.clinicalgenome.org/r/6f55df01-1ac7-4ff5-856e-5d95bfee731a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004317.4(GET3):c.913C>T (p.Gln305Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA404282838"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/07712ae9-6f85-44a0-b030-996483e197cd","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/07712ae9-6f85-44a0-b030-996483e197cd_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Protein expression via Western blot comparing II:2 to healthy controls, in vitro tail-anchored protein insertion assay (Figure 4)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/07712ae9-6f85-44a0-b030-996483e197cd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31461301","allele":{"id":"https://genegraph.clinicalgenome.org/r/f42a9455-4884-4602-be25-785456541e91","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004317.4(GET3):c.488T>C (p.Val163Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA404276407"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d3f95b49-7620-4250-a794-c9af895f281b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31461301","rdfs:label":"II:2","ageType":"AgeAtOnset","ageUnit":"Weeks","ageValue":2,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/6f55df01-1ac7-4ff5-856e-5d95bfee731a"},{"id":"https://genegraph.clinicalgenome.org/r/f42a9455-4884-4602-be25-785456541e91"}],"detectionMethod":"Targeted next-gen sequencing of 48 cardiomyopathy genes yielded no potentially deleterious variants. Trio exome sequencing in II-2 and parents revealed 3 potentially deleterious variants in GET3.","firstTestingMethod":"Next generation sequencing panels","previousTesting":true,"previousTestingDescription":"Biochemical, hematologic, viral, and metabolic testing was noted unremarkable outside of slightly abnormal serum transferrin and apolipoprotein C-III isoelectric focusing profiles.","secondTestingMethod":"Exome sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/07712ae9-6f85-44a0-b030-996483e197cd_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/e433e2f3-7a23-45d2-b1f3-b7d297e7ebc2_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/605f9805-5af1-445a-911a-d31ebff15125_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/10ee7c70-da10-485b-8828-f1fb7a2ec53f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31461301","rdfs:label":"Family 1","estimatedLodScore":0.98,"family":{"id":"https://genegraph.clinicalgenome.org/r/10ee7c70-da10-485b-8828-f1fb7a2ec53f","type":"Family","rdfs:label":"Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/d3f95b49-7620-4250-a794-c9af895f281b"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/d3f95b49-7620-4250-a794-c9af895f281b"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":1.5}],"evidenceStrength":"Limited","sequence":10897,"specifiedBy":"GeneValidityCriteria11","strengthScore":4,"subject":{"id":"https://genegraph.clinicalgenome.org/r/-XAWwqI3ah4","type":"GeneValidityProposition","disease":"obo:MONDO_0005021","gene":"hgnc:752","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_605f9805-5af1-445a-911a-d31ebff15125-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}